Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment
Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment |
|
https://doi.org/10.18632/oncotarget.26028
Shohei Koyama,
Izumi Nagatomo,
Takashi Kijima,
and Atsushi Kumanogoh
|
| 32552-32553 |
Balance deficits in long-term pediatric ALL survivors
Balance deficits in long-term pediatric ALL survivors |
|
https://doi.org/10.18632/oncotarget.25967
Mitra Varedi,
Kirsten K. Ness,
and Raymond F. McKenna
|
| 32554-32555 |
Tumor cell density regulates matrix metalloproteinases for enhanced migration
Tumor cell density regulates matrix metalloproteinases for enhanced migration |
|
https://doi.org/10.18632/oncotarget.25863
Hasini Jayatilaka,
Fatima G. Umanzor,
Vishwesh Shah,
Tomer Meirson,
Gabriella Russo,
Bartholomew Starich,
Pranay Tyle,
Jerry S.H. Lee,
Shyam Khatau,
Hava Gil-Henn,
and Denis Wirtz
|
| 32556-32569 |
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors |
|
https://doi.org/10.18632/oncotarget.25948
Lise Barlebo Ahlborn,
Ida Viller Tuxen,
Florent Mouliere,
Savvas Kinalis,
Ane Y. Schmidt,
Kristoffer Staal Rohrberg,
Eric Santoni-Rugiu,
Finn Cilius Nielsen,
Ulrik Lassen,
Christina Westmose Yde,
Olga Oestrup,
and Morten Mau-Sorensen
|
| 32570-32579 |
Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis
Chromatin remodeling protein HELLS is upregulated by inactivation of the RB-E2F pathway and is nonessential for osteosarcoma tumorigenesis |
|
https://doi.org/10.18632/oncotarget.25953
Stephanie C. Wu,
and Claudia A. Benavente
|
| 32580-32592 |
Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells
Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25961
Sanna S. Virtanen,
Tamiko Ishizu,
Jouko A. Sandholm,
Eliisa Löyttyniemi,
H. Kalervo Väänänen,
Johanna M. Tuomela,
and Pirkko L. Härkönen
|
| 32593-32608 |
Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells
Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells |
|
https://doi.org/10.18632/oncotarget.25975
Yoshihiro Koya,
Wenting Liu,
Yoshihiko Yamakita,
Takeshi Senga,
Kiyosumi Shibata,
Mamoru Yamashita,
Akihiro Nawa,
Fumitaka Kikkawa,
and Hiroaki Kajiyama
|
| 32609-32623 |
Quantitative screening of serum protein biomarkers by reverse phase protein arrays
Quantitative screening of serum protein biomarkers by reverse phase protein arrays |
|
https://doi.org/10.18632/oncotarget.25976
Zhizhou Kuang,
Ruochun Huang,
Zhimin Yang,
Zhiqiang Lv,
Xinyan Chen,
Fuping Xu,
Yu-Hua Yi,
Jian Wu,
and Ruo-Pan Huang
|
| 32624-32641 |
Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy
Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy |
|
https://doi.org/10.18632/oncotarget.25982
Endang Nuryadi,
Yasushi Sasaki,
Yoshihiko Hagiwara,
Tiara Bunga Mayang Permata,
Hiro Sato,
Shuichiro Komatsu,
Yuya Yoshimoto,
Kazutoshi Murata,
Ken Ando,
Nobuteru Kubo,
Noriyuki Okonogi,
Yosuke Takakusagi,
Akiko Adachi,
Mototaro Iwanaga,
Keisuke Tsuchida,
Tomoaki Tamaki,
Shin-ei Noda,
Yuka Hirota,
Atsushi Shibata,
Tatsuya Ohno,
Takashi Tokino,
Takahiro Oike,
and Takashi Nakano
|
| 32642-32652 |
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis
The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis |
|
https://doi.org/10.18632/oncotarget.25987
Kiyoko Takane,
Masaki Fukuyo,
Keisuke Matsusaka,
Satoshi Ota,
Bahityar Rahmutulla,
Kazuyuki Matsushita,
Hideaki Miyauchi,
Yukio Nakatani,
Hisahiro Matsubara,
and Atsushi Kaneda
|
| 32653-32666 |
Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells
Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25994
Shuhei Suzuki,
Masashi Okada,
Hiroyuki Takeda,
Kenta Kuramoto,
Tomomi Sanomachi,
Keita Togashi,
Shizuka Seino,
Masahiro Yamamoto,
Takashi Yoshioka,
and Chifumi Kitanaka
|
| 32667-32679 |
Absence of correlation between radiation-induced CD8 T-lymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation
Absence of correlation between radiation-induced CD8 T-lymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation |
|
https://doi.org/10.18632/oncotarget.26001
Guillaume Vogin,
Jean-Louis Merlin,
Alexandra Rousseau,
Didier Peiffert,
Alexandre Harlé,
Marie Husson,
Labib El Hajj,
Mihai Levitchi,
Tabassome Simon,
and Jean-Marc Simon
|
| 32680-32689 |
A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3)
A high-throughput fluorescence polarization assay for discovering inhibitors targeting the DNA-binding domain of signal transducer and activator of transcription 3 (STAT3) |
|
https://doi.org/10.18632/oncotarget.26013
Po-Chang Shih,
Yiwen Yang,
Gary N. Parkinson,
Andrew Wilderspin,
and Geoffrey Wells
|
| 32690-32701 |
Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer
Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer |
|
https://doi.org/10.18632/oncotarget.26021
Thomas Prince,
Andrew Ackerman,
Alice Cavanaugh,
Brielle Schreiter,
Brendon Juengst,
Chaylen Andolino,
John Danella,
Mitch Chernin,
and Heinric Williams
|
| 32702-32717 |
A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis
A patient-derived orthotopic xenograft model enabling human high-grade urothelial cell carcinoma of the bladder tumor implantation, growth, angiogenesis, and metastasis |
|
https://doi.org/10.18632/oncotarget.26024
Jessie Gills,
Ravan Moret,
Xin Zhang,
John Nelson,
Grace Maresh,
Linh Hellmers,
Daniel Canter,
M’Liss Hudson,
Shams Halat,
Marc Matrana,
Michael P. Marino,
Jakob Reiser,
Maureen Shuh,
Eric Laborde,
Maria Latsis,
Sunil Talwar,
Stephen Bardot,
and Li Li
|
| 32718-32729 |
Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo
Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo |
|
https://doi.org/10.18632/oncotarget.26065
Hong Yang,
Liuyuan Guan,
Shun Li,
Ying Jiang,
Niya Xiong,
Li Li,
Chunhui Wu,
Hongjuan Zeng,
and Yiyao Liu
|
| 32730-32730 |
Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy |
|
https://doi.org/10.18632/oncotarget.26066
Marta Mellai,
Monica Cattaneo,
Alessandra Maria Storaci,
Laura Annovazzi,
Paola Cassoni,
Antonio Melcarne,
Pasquale De Blasio,
Davide Schiffer,
and Ida Biunno
|
| 32731-32731 |
